Uskoro zabrana endok­rinih disruptora


13 lipnja 2016

Europski parlament je utro put za novu tužbu protiv Europske komisije, ako ona u roku od dva mjeseca ne poduzme mjere protiv endokrinih disruptora. Dnevna uprava EU-a je u 2013. godini trebala početi s skidanjem endokrinih disruptora sa tržišta, ali je to zbog ekonomskih razloga do sada uvijek odbijala.

tomaten

Tvari koje poremećuje hormone se, između ostalog, mogu naći u plastičnim posudama, kozmetici i poprskanim voćem i povrćem. Kemikalije mogu uzrokovati bolesti kao što su rak dojke, rak testisa i probleme s plodnošću.

Ovo je posljednja šansa za Europsku komisiju da konačno počne braniti zdravlje ljudi i životinja; šansa koju Komisija zapravo nije zaslužila,” kaže Europski zastupnik Anja Hazekamp.

Zadnji rok za uspostavu kriterija za skidanje endokrinih disruptora sa tržišta je bio je 13. prosinca 2013. Europska komisija više od dvije godine namjerno ugrožava naše zdravlje, jer se boji da bi moglo biti previše troškova za industriju. Europski parlament je jasno pokazao da naše zdravlje treba biti prioritet, a ne veliki novac od multinacionalnih kompanija,” rekla je Hazekamp. “Endokrini disruptori se direktno moraju skinuti sa tržišta i polu-mjere neće biti prihvaćene.

The European Parliament has opened the way for a new trial against the European Commission, if they do not take action against endocrine disruptors within the next two months. The Commission, responsible for the day-to-day management of the EU, should in fact have started taking endocrine disruptors off the market back in 2013, but to date has refused to do so due to economic considerations.

tomaten

Endocrine disruptors are found in plastic packaging, cosmetics and sprayed vegetables and fruits, among others. The chemical substances can cause a variety of conditions, including breast cancer, testicular cancer and fertility problems.

This is one last chance for the European Commission to finally make a stand for public and animal health: a chance the Commission actually does not deserve,” according to MEP Anja Hazekamp.

The deadline for establishing criteria which allow for endocrine disruptors to be taken off the market, was 13 December 2013. For over two years, the European Commission has wilfully gambled with public health, simply because it fears it might cost the industry too much. The European Parliament has made clear that it is our health that should have first priority – not the big money of multinationals,” states Hazekamp. “Endocrine disruptors should be taken off the market instantly, and half-measures will not be accepted.